ARCHIVES

Advisors Clear Herceptin; Find Tamoxifen Indicated For “Short Term Risk Reduction”

This article is from The Cancer Letter archive.

Vol. 24 No. 34 | September 11, 1998

Download PDF Visit The Full Archive

Related Articles

Kington Named Acting NIH Director.

November 14, 2008

Adamson Objects to IOM “Primrose Path of Centralization” In Report

March 3, 1989

NCI Advisory Group Meetings for July

June 27, 1975

Frederick Center Should Have Top Scientist As Director, 20% Of Budget or Basic Research

December 21, 1973

Obey Convinces House Hew Subcommittee to Cut $17 Million Control, Give It To Bioassays

June 1, 1979

In Brief: Carcinogenesis: Does The Promise Justify The Effort? Task Force Attempts To Find Out

September 30, 1977